ArticleThe Journal of adolescent health : official publication of the Society for Adolescent Medicine2014
Factors associated With Medicaid providers' recommendation of the HPV vaccine to low-income adolescent girls.
Article in The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- US Health Care Clinicians' Knowledge, Attitudes, and Practices Regarding Human Papillomavirus Vaccination: A Qualitative Systematic Review.Academic pediatrics · 2018Pooled it
- Provider communication about HPV vaccination: A systematic review.Human vaccines & immunotherapeutics · 2016Pooled it
- Cancer-salient messaging for Human Papillomavirus vaccine uptake: A randomized controlled trial.Vaccine · 2018Trial
- Beyond the check-up: how well-child exams, pediatric specialists, and provider recommendations can close HPV vaccine gaps for Chinese American Teens.Cancer causes & control : CCC · 2026Article
- Trusted health system implementation strategies to increase vaccination (TRUE SYNERGI): a stepped-wedge cluster randomized trial to reduce HPV-related cancers.BMC public health · 2025Article
- Los Angeles County dentists' opinions on discussing human papilloma virus-related oral health issues and recommending vaccine to patients.Human vaccines & immunotherapeutics · 2024Article
- Article
- Barriers to the assessment and recommendation of HPV vaccination among healthcare providers in Texas.Vaccine: X · 2024Article
- Optimizing timing of adolescent vaccines: Impact of initiating HPV vaccination before Tdap or meningococcal vaccination on timely completion of the HPV vaccine series.Human vaccines & immunotherapeutics · 2023Article
- HPV vaccine recommendations by age: A survey of providers in federally qualified health centers.Human vaccines & immunotherapeutics · 2023Article
- HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US.Human vaccines & immunotherapeutics · 2023Article
- Barriers and determinants of consistent offering of HPV vaccination by healthcare facilities.Human vaccines & immunotherapeutics · 2023Article
- Individual, systemic and state factors associated with provider recommendation of HPV vaccination: Findings from NIS-Teen, 2020.Human vaccines & immunotherapeutics · 2023Article
- A qualitative descriptive study of providers' perspectives on human papillomavirus vaccine administration among Latino/a adolescents in South Texas clinics: barriers and facilitators.BMC public health · 2022Article
- Healthcare Providers' Vaccine Perceptions, Hesitancy, and Recommendation to Patients: A Systematic Review.Vaccines · 2021Review
- HPV vaccination prevalence, parental barriers and motivators to vaccinating children in Hawai'i.Ethnicity & health · 2020Article
- Parental awareness and utilization of meningococcal serogroup B vaccines in the United States.BMC public health · 2020Article
- Educating healthcare providers to increase Human Papillomavirus (HPV) vaccination rates: A Qualitative Systematic Review.Vaccine: X · 2019Review
- Clinician offering is a key factor associated with HPV vaccine uptake among Mexican mothers in the USA and Mexico: a cross-sectional study.International journal of public health · 2019Article
- An environmental scan to examine stakeholder perspectives on human papillomavirus vaccination: A mixed methods study.Vaccine · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeHuman papillomavirus (HPV) vaccination in the United States remains a public health challenge with vaccine rates of 50%. Although health care providers can facilitate HPV vaccination, several factors may impede their ability to universally recommend the vaccine. To maximize the potential of HPV vaccines, it is important to understand challenges providers face in the clinical environment. The study sought to identify factors associated with recommendation of the HPV vaccine for low-income adolescents in the early (9-10), target (11-12), early adolescent catch-up (13-14), and late adolescent catch-up (15-17) vaccination groups.
methodsSurveys were mailed between October 2009 and April 2010 to a random sample of Florida-based physicians serving Medicaid-enrolled adolescents. Data were analyzed in 2013.
resultsAmong early adolescents, discomfort discussing sexually transmitted infections (STIs) with teens (odds ratio [OR] = 1.75), difficulty ensuring vaccine completion (OR = .73), and discomfort discussing STIs with parents (OR = .44) were associated with recommendation. For target adolescents, discomfort discussing STIs with teens (OR = 2.45), time constraints (OR = .70), vaccine efficacy concerns (OR = .65), discomfort discussing STIs with parents (OR = .33), obstetrics/gynecology (OR = .25) and family medicine (OR = .24) specialty, and non-Hispanic black patient (OR = .15) were associated with recommendation. In early catch-up adolescents, concerns that teens will practice riskier behaviors (OR = .57), discomfort discussing STIs with parents (OR = .47), and family medicine specialty (OR = .20) were associated with recommendation. For late catch-up adolescents, family medicine specialty (OR = .13) was associated with recommendation.
conclusionsModifiable factors that impede or influence provider recommendations of HPV vaccines can be addressed through intervention. Overall, findings suggest that efforts should focus on sexuality communication and family medicine specialty.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.